Genetic ablation of Dpp4 in mice [24] improves insulin sensitivity and liver glucose metabolism, and DPP4 pharmacological inhibition reduces the development of hepatic steatosis and insulin resistance in mouse models of obesity and diabetes [25, 26]. This evidence concerns the gene DPP4 and obesity disorder.